Paul Wurzer1, Ludwik K Branski, Robert P Clayton, Gabriel Hundeshagen, Abigail A Forbes, Charles D Voigt, Clark R Andersen, Lars-P Kamolz, Lee C Woodson, Oscar E Suman, Celeste C Finnerty, David N Herndon. 1. *Department of Surgery, University of Texas Medical Branch, Galveston, Texas †Shriners Hospitals for Children-Galveston, Galveston, Texas ‡Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery, Medical University of Graz, Graz, Austria §Sealy Center for Molecular Medicine and the Institute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas ||School of Medicine, University of Texas Medical Branch, Galveston, Texas ¶Department of Anesthesiology, University of Texas Medical Branch, Galveston, Texas.
Abstract
PURPOSE: The aim of this study was to quantify the effect of propranolol on hemodynamic parameters assessed using the PiCCO system in burned children. METHODS: We analyzed hemodynamic data from patients who were randomized to receive either propranolol (4 mg/kg/day) or placebo (control), which was initiated as a prospective randomized controlled trial. Endpoints were cardiac index (CI), percent predicted heart rate (%HR), mean arterial pressure (MAP), percent predicted stroke volume (%SV), rate pressure product (RPP), cardiac work (CW), systemic vascular resistance index (SVRI), extravascular lung water index (EVLWI), arterial blood gases, events of lactic acidosis, and mortality. Mixed multiple linear regressions were applied, and a 95% level of confidence was assumed. RESULTS:One hundred twenty-one burned children (control: n = 62, propranolol: n = 59) were analyzed. Groups were comparable in demographics, EVLWI, SVRI, %SV, arterial blood gases, Denver 2 postinjury organ failure score, incidence of lactic acidosis, or mortality. Percent predicted HR, MAP, CI, CW, and RPP were significantly reduced in the propranolol-treated group (P <0.01). CONCLUSIONS:Propranolol significantly reduces cardiogenic stress by reducing CI and MAP in children with severe burn injury. However, peripheral oxygen delivery was not reduced and events of lactic acidosis as well as organ dysfunction was not higher in propranolol treated patients.
RCT Entities:
PURPOSE: The aim of this study was to quantify the effect of propranolol on hemodynamic parameters assessed using the PiCCO system in burned children. METHODS: We analyzed hemodynamic data from patients who were randomized to receive either propranolol (4 mg/kg/day) or placebo (control), which was initiated as a prospective randomized controlled trial. Endpoints were cardiac index (CI), percent predicted heart rate (%HR), mean arterial pressure (MAP), percent predicted stroke volume (%SV), rate pressure product (RPP), cardiac work (CW), systemic vascular resistance index (SVRI), extravascular lung water index (EVLWI), arterial blood gases, events of lactic acidosis, and mortality. Mixed multiple linear regressions were applied, and a 95% level of confidence was assumed. RESULTS: One hundred twenty-one burned children (control: n = 62, propranolol: n = 59) were analyzed. Groups were comparable in demographics, EVLWI, SVRI, %SV, arterial blood gases, Denver 2 postinjury organ failure score, incidence of lactic acidosis, or mortality. Percent predicted HR, MAP, CI, CW, and RPP were significantly reduced in the propranolol-treated group (P <0.01). CONCLUSIONS:Propranolol significantly reduces cardiogenic stress by reducing CI and MAP in children with severe burn injury. However, peripheral oxygen delivery was not reduced and events of lactic acidosis as well as organ dysfunction was not higher in propranolol treated patients.
Authors: Paul Wurzer; Ludwik K Branski; Marc G Jeschke; Arham Ali; Michael P Kinsky; Fredrick J Bohanon; Gabriel Hundeshagen; William B Norbury; Felicia N Williams; Lars-P Kamolz; Celeste C Finnerty; David N Herndon Journal: Shock Date: 2016-09 Impact factor: 3.454
Authors: Giles N Cattermole; P Y Mia Leung; Paulina S K Mak; Stewart S W Chan; Colin A Graham; Timothy H Rainer Journal: Crit Care Med Date: 2010-09 Impact factor: 7.598
Authors: Mónica Moreira-Rodrigues; Ana L Graça; Marlene Ferreira; Joana Afonso; Paula Serrão; Manuela Morato; Fátima Ferreirinha; Paulo Correia-de-Sá; Steven N Ebert; Daniel Moura Journal: J Pharmacol Exp Ther Date: 2014-08-26 Impact factor: 4.030
Authors: Ludwik K Branski; David N Herndon; Jaron F Byrd; Michael P Kinsky; Jong O Lee; Shawn P Fagan; Marc G Jeschke Journal: Crit Care Date: 2011-04-21 Impact factor: 9.097
Authors: Manuel Sánchez; Abelardo García-de-Lorenzo; Eva Herrero; Teresa Lopez; Beatriz Galvan; María Asensio; Lucia Cachafeiro; Cesar Casado Journal: Crit Care Date: 2013-08-15 Impact factor: 9.097
Authors: Celeste C Finnerty; Karel D Capek; Charles Voigt; Gabriel Hundeshagen; Janos Cambiaso-Daniel; Craig Porter; Linda E Sousse; Amina El Ayadi; Ramon Zapata-Sirvent; Ashley N Guillory; Oscar E Suman; David N Herndon Journal: J Trauma Acute Care Surg Date: 2017-09 Impact factor: 3.313
Authors: Christian Tapking; Daniel Popp; David N Herndon; Ludwik K Branski; Ronald P Mlcak; Oscar E Suman Journal: Burns Date: 2018-07-10 Impact factor: 2.744
Authors: David Herndon; Karel D Capek; Evan Ross; Jayson W Jay; Anesh Prasai; Amina El Ayadi; Guillermo Foncerrada-Ortega; Elizabeth Blears; Christian Sommerhalder; Kara McMullen; Dagmar Amtmann; Robert Cox; Gabriel Hundeshagen; Kristofer Jennings; Linda E Sousse; Oscar E Suman; Walter J Meyer; Celeste C Finnerty Journal: Ann Surg Date: 2018-09 Impact factor: 12.969